Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-114206·KALA BIO, Inc.
Schedule 13G ownership disclosure
KALA BIO INC
Common Stock, par value $0.001 per share · CUSIP: 483119202
Event date: 2025-09-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 543,745 · Class: 7.7%
- Joseph Edelman
Shares: 543,745 · Class: 7.7%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 543,745 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-114206
- Form type
- SCHEDULE 13G
- Filer
- KALA BIO, Inc.
- CIK
- CIK 1479419
- Filed
- Sep 11, 2025
- Reporting period
- Sep 04, 2025
- Description
- Schedule 13G beneficial ownership